New Medtech Standards In China Warrant Close Attention By Firms, Expert Says
This article was originally published in The Gray Sheet
Executive Summary
The influx of new mandatory and voluntary standards that will take effect in the next two years have important implications for companies' ability to launch new products and maintain current products on the market in China, a locally based attorney says.